I must apologize first for not blogging on Monday and Tuesday, but I was on a ski trip with the family and not thinking about the markets.  My alert for Monday (BLGW) is doing very well I’m happy to report.

I jumped back in to my research this morning and came across a great company that has solid prospects:  Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis:physiological process involving the growth of new blood vessels from pre-existing vessels).

GTF’s AutoloGel System utilizes a unique technology that enables rapid isolation and activation of platelet rich plasma (PRP) from a patient’s own blood. The PRP is subsequently processed to produce a gel for application to the wound bed, re-establishing a balance needed for natural healing to occur. AutoloGel contains growth factors, cytokines and chemokines that are essential for normal wound healing. The AutoloGel System is used at the point-of care and is the only PRP System indicated for use in exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically-debrided wounds.  The AutoloGel System is the only PRP system that is FDA cleared for the care of wounds.

The company is generating revenues and those revenues are increasing significantly.  They have cash-in-the-bank and NO long term debt….always a positive sign for me.  With the 2009 capital raise, that bought the company some time to execute on their plan.  Based upon what I have seen, they have high expectations for their AutoloGel System.

The chart indicates that the stock is trading near the bottom of its most recent trading range.

• After a steep selloff, the stock might be ready to run again
• An Amex stock, GTF is trading at attractive levels
• The strongest support is at 40 cents (see the chart)…. I don’t think it will drop that far, but it could
  

I am recommending that traders put GTF on their radar screens.  I think the downside risk is low, but the upside is strong.

As always, do your own due diligence.

Good luck and good trading,

Jeffrey Dean

Editor

Winning Brands is currently a penny stock that has flirted with sub-penny stock  status very recently and then seemed like it was going to be  dollar stock…all in the space of a few weeks.

As you will see in the accompanying chart, Winning Brands, Inc. (WNDB) has been on a roller coaster ride of late.

I would look for some more confirmation that the stock is basing here at these levels.  It is highly volatile and appears to be under accumulation.

Winning Brands is one of those “take it on faith” stocks….because, there is not a great deal of  information available about them other than some PR, a website and a few filings.  They have made claims that they are going to be fully reporting.  I have talked to the company and they say that they are working aggressively towards that goal.

The company itself has a complete line of eco-friendly cleaning products that they are selling through retail outlets worldwide.  I have some experience in retail and while it is important for WNBD to get broad distribution, it is also important that they back up sales with ads, buzz, point-of-sale promotions….all stuff that costs money that WMBD doesn’t have yet.

They are on a fund raising campaign and will need every penny to make a splash in the market.  I did a very unscientific study and called my local paint store that carried WNBD’s products.  The counter person, at first, didn’t even know they carried it.  I insisted because I saw it on the site and she then located it.  I was hoping for a “gee whiz” testimonial about how this was the greatest product ever.  But, I didn’t get that.

That is, however, what WNBD needs to achieve….. A buzz that will carry the name of the company and its products to the four corners of the globe, literally.  Their “Extreme Home Makeover” tie-in is great, but where are the Billy Mays-type infomercials?  According to a December PR, they are working on a Direct Response ad program.  If that gets seen, it could be HUGE for the company.

WNBD might be a good little trader. It is building a following from what I read on the boards and it has a “story to tell”.  Any break below $.01 and the stock should be avoided.  But, if it can hold this level, then it might be a good entry point.  News and rumor are going to drive this company’s stock.

Be fast, be nimble with WNBD.

Good luck and good trading,

Jeffrey Dean

Note: Yahoo! Finance lists the name of WNBD as Global eTutor, Inc.  Google Finance and Pinksheets.com list it as Winning Brands, Inc.  This must be one of those corporate shells issues.

*******************************************************************

A little company called Green Energy Live, Inc. (GELV) literally came out of nowhere in December of 2009 for my members.  A MASSIVE gain of 120% was the highlight of a very good December for Soup members.

Well, GELV is back! I track companies that we have done alerts for in the past and am excited to bring this one back to members.

Everyone knows that past performance is no predictor of the future, so I am not guaranteeing anything.  However, I still like GELV and think that it might be a great trade, again! continue

My apologies to the movie Network, but I am really ticked at Kender Energy, Inc. (KNDR).  Here is a company that seemingly had “the world on a string” and I believe has really let traders down.  Right now, the company is at the mercy of the discussion boards and chat rooms.

What do I mean ” at the mercy of discussion boards and chat rooms”?  It means that the company has, for all intents and purposes, disappeared.  The last PR was December of ‘09.  The PR before that was for the signing up of a distributor in one of the largest markets in the world…..Hawaii?  Two problems with that is that Hawaii is tiny AND KNDR doesn’t even have a working prototype.   The only “news” I get is on the boards and you know how reliable that is!

KNDR has a very exciting solar technology that they are touting.  (Web link here)  I have talked to a number of people about KNDR and they all agree that IF they can commercialize it, the technology could be huge.  According to my sources, KNDR MIGHT have an Alpha system by mid-2010.  What is an investor to do until then?

Since I like KNDR’s technology so much, I have gone over and above the “call of duty” to do research on them.  I called their IR firm (who is out of business and not returning calls), I have emailed the company on numerous occasions and I have talked with others about KNDR.  The company never got back to me and no one had any inside info on the company.

Here is their chart….You can see a steady decline and a lack of interest on the part of traders.

Will KNDR become a sub-penny stock?  It could, but I doubt it.  The company needs to put out some meaningful PR and let traders know that they have a pulse. If they get some news, this stock could rocket! There are a lot of people in the stock and they are rooting for it, too.

Be careful of the boards.  Many of the posts that I am seeing are highly suspect.

I am rooting for KNDR and their “solar engine”.  I am just not rooting that hard.

Good luck and good trading,

Jeffrey Dean

Editor’s note on 2-4-10 - I got an email from Robert F about KNDR that I thought made great sense.  Here is what he wrote:  “Read your blog, I agree with you that the company has been too silent. You would think that at a time when the company is in need of investor support, that they would give shareholders more transparency.” I couldn’t agree more

*****************************************************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

There is already a huge industry in America built around converting biomass into biofuel. Most of that conversion involves sugar, corn and corn kernel starch.  These readily available feed stocks seemed to be the perfect solution as a replacement of hydrocarbon-based fuels.  What planners didn’t realize is that corn and grain prices worldwide would skyrocket as biofuels were competing with food producers and growers for a finite amount of feed. What is needed is the next generation of biofuels that don’t rely upon scarce supplies of a pricey commodity.

That is where Raven Biofuels Corporation (RVBF) comes in!
continue

Carbon Dioxide (CO2) has gotten a bad rap for causing pollution, the greenhouse effect AND global warming.  Deservedly so, in most cases.

Fossil fuels such as oil, gas and coal have powered the world’s economic growth since the days of the industrial revolution.   As the world economies expand, so does the need for fossil fuels.  The U.S. Energy Information Administration projects that global energy consumption will increase 50% by 2030 to over 112 million barrels of crude oil per day.  The economic cost is significant with the price of oil and coal setting new highs seemingly every day, but the environmental impact is staggering with BILLIONS of tons of CO2 into the atmosphere annually.

What if there was a way to turn that pollution into profits?

Yes!  That is what today’s alert company Carbon Sciences, Inc. (CABN) is doing! continue

One of the alert stocks that I really liked from a few months back was Vivakor, Inc. (VIVK). It was a biotechnology firm that had revenues, patents in place, a full product pipeline and great prospects.  The stock went out on alert and generated a 20% gain…..but, nothing like what I was expecting.

Once I do my DD on companies, I tend to watch them.  And, I watched VIVK plummet shortly after our alert.  I wasn’t sure why…..there was no negative news, volume remained “adequate”, nothing adverse came to mind.  Now that the stock is at .15/.16, I think that NOW is the time to take another look at VIVK.

When stocks go down without adverse news like VIVK, it means that there are significantly more sellers than buyers (no kidding).  In my conversations with people in and around VIVK, it appears that there was a group of investors that decided to get out while the stock was at high levels and unloaded all of their shares on the market.  These investors (I can only assume) had low, low cost “founder’s shares” and selling them at 63 cents (the most recent high) and down would be a HUGE windfall for them.

Here is an annotated chart, so you can see what I mean.

Vivakor, the company, is an interesting study. It is not a pharma biotech, but rather have a focus on equipment and consumables for the biotech industry.  That is not to say that they don’t have an important R & D component to their business, but in this niche they are, in my opinion, much easier to understand.  I have never claimed to be a pharma/biotech expert and many times I have a hard time understanding the products from a pure pharma/biotech play.

Some of this info is pulled from my original alert, such as:

VIVK has an astonishing breadth and depth of products, technologies and intellectual property.  It conducts research in four primary areas of medical and biotechnological development:

• Molecular medicine
• electro-optics
• biological handling
• and natural and formulary compounds (i.e. nutraceuticals)

The company has (at last count) over 12 products in various stages of FDA approval (with the related patents filed and patent-pending). Here is a link to their site that will allow you to review it for yourself.  It is well put together and very informative.

Here is a list of products under development:

• VivaThermic Vials for cryopreservation - Phase III
• VivaBlend for antioxidant supplements - Phase III
• CryoKeeper/Carrier, a device for the storage and transport of specimens at cryogenic temperatures - Phase II
• VivaSight, a digital photorefractor for children’s vision screening - Phase II
• VivAuris, a device for middle ear redness detection - Phase II
• VivaGlobin, a device for anemia and cutaneous hemoglobin detection - Phase II
• RejuviJam, which is a jam and jelly with antioxidants and bone and cartilage supplements - Phase II
• SLICES, a magnetic resonance imaging enhancement software - Phase II
• Vivaplate, a microplate for rapid temperature response - Phase I
• VivaCycler, a heating and cooling device - Phase I
• Cryopsy, a device for cryogenic biopsy collection of visceral lesions - Phase I
• VivaGastroProtect, which are fruits and vegetables extract for the protection of digestive system - Phase I
• VivaCrop, a vegetation health monitor - Phase I
• Clinical Biomolecular Sensor -  an in vitro diagnostic device used at the point of care. It also provides contract research and development services in molecular biology, device engineering, and other areas - Phase I

Revenues are still insignificant compared to the expenses, but with several products in phase III FDA trials, that could change rapidly upon approval.  I am also watching to see if their announcement of a $5MM deal with Regenca for their nutraceutical product generates any near-term revenues.  The Veritas deal for the sale of Vivathermic vials in Japan is also one that I am watching to see if it brings any significant income.

The 9-30-09 balance sheet doesn’t inspire awe, but it is not untypical for a small biotech firm like VIVK.  It appears that they will have to get some outside financing from somewhere in order to continue in operations.  They have minimal debt, but poor liquidity ratios.  VIVK also announced that they are looking for acquistions.  The way these things usually work is that VIVK will convince the owners of a private company to be acquired giving them access to the public markets and easy liquidity for the value of their company.  Usually in deals like these, very little cash changes hands and it is all done in shares.  That makes it EVEN MORE IMPORTANT for VIVK to get their share price up.

I like the company and think I understand why it has taken a dive.  I get the feeling that the company is ticked that their stock price took a dive and are doing things to change that. It is in their own best interest to get the stock price up…and, I think they will.

I don’t know why I always say this, but “I never call a bottom”. But, this is definitely a radar stock.  I had an order in yesterday for VIVK that didn’t get filled (I was trying to scalp a penny) and I will probably try again today.

Good luck and good trading,

Jeffrey Dean, Editor

******************************************************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company,  Investor Soup had previously been compensated to cover VIVK in December of 2009.  That agreement has expired. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.